These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31579650)

  • 1. TB treatment delay associated with drug resistance and admission at Daru General Hospital in Papua New Guinea.
    Hapolo E; Ilai J; Francis T; du Cros P; Taune M; Chan G
    Public Health Action; 2019 Sep; 9(Suppl 1):S50-S56. PubMed ID: 31579650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emergency response to multidrug-resistant tuberculosis in Daru, Western Province, Papua New Guinea, 2014-2017.
    Morris L; Hiasihri S; Chan G; Honjepari A; Tugo O; Taune M; Aia P; Dakulala P; Majumdar SS
    Public Health Action; 2019 Sep; 9(Suppl 1):S4-S11. PubMed ID: 31580333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of screening and management of household contacts of tuberculosis cases in Daru, Papua New Guinea.
    Honjepari A; Madiowi S; Madjus S; Burkot C; Islam S; Chan G; Majumdar SS; Graham SM
    Public Health Action; 2019 Sep; 9(Suppl 1):S25-S31. PubMed ID: 31579646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Evidence of Drug-Resistant Tuberculosis in the Balimo Region of Papua New Guinea.
    Diefenbach-Elstob T; Guernier V; Burgess G; Pelowa D; Dowi R; Gula B; Puri M; Pomat W; McBryde E; Plummer D; Rush C; Warner J
    Trop Med Infect Dis; 2019 Feb; 4(1):. PubMed ID: 30744192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.
    Cox H; Dickson-Hall L; Ndjeka N; Van't Hoog A; Grant A; Cobelens F; Stevens W; Nicol M
    PLoS Med; 2017 Feb; 14(2):e1002238. PubMed ID: 28222095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors.
    Xu C; Li R; Shewade HD; Jeyashree K; Ruan Y; Zhang C; Wang L; Zhang H
    PLoS One; 2019; 14(4):e0214943. PubMed ID: 30958841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study.
    Soeroto AY; Lestari BW; Santoso P; Chaidir L; Andriyoko B; Alisjahbana B; van Crevel R; Hill PC
    PLoS One; 2019; 14(2):e0213017. PubMed ID: 30818352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot model of patient education and counselling for drug-resistant tuberculosis in Daru, Papua New Guinea.
    Adepoyibi T; Keam T; Kuma A; Haihuie T; Hapolo M; Islam S; Akumu B; Chani K; Morris L; Taune M
    Public Health Action; 2019 Sep; 9(Suppl 1):S80-S82. PubMed ID: 31579655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond patient delay, navigating structural health system barriers to timely care and treatment in a high burden TB setting in Papua New Guinea.
    Jops P; Cowan J; Kupul M; Trumb RN; Graham SM; Bauri M; Nindil H; Bell S; Keam T; Majumdar S; Pomat W; Marais B; Marks GB; Kaldor J; Vallely A; Kelly-Hanku A
    Glob Public Health; 2023 Jan; 18(1):2184482. PubMed ID: 36883701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of tuberculosis in the rural Balimo region of Papua New Guinea.
    Diefenbach-Elstob T; Graves P; Dowi R; Gula B; Plummer D; McBryde E; Pelowa D; Siba P; Pomat W; Warner J
    Trop Med Int Health; 2018 Sep; 23(9):1022-1032. PubMed ID: 29920858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa.
    Evans D; Sineke T; Schnippel K; Berhanu R; Govathson C; Black A; Long L; Rosen S
    BMC Health Serv Res; 2018 Dec; 18(1):973. PubMed ID: 30558670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delay in diagnosis and treatment among adult multidrug resistant tuberculosis patients in Yangon Regional Tuberculosis Center, Myanmar: a cross-sectional study.
    Htun YM; Khaing TMM; Yin Y; Myint Z; Aung ST; Hlaing TM; Soonthornworasiri N; Silachamroon U; Kasetjaroen Y; Kaewkungwal J
    BMC Health Serv Res; 2018 Nov; 18(1):878. PubMed ID: 30458776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delays to anti-tuberculosis treatment intiation among cases on directly observed treatment short course in districts of southwestern Ethiopia: a cross sectional study.
    Asres A; Jerene D; Deressa W
    BMC Infect Dis; 2019 May; 19(1):481. PubMed ID: 31142288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delay in treatment initiation and treatment outcomes among adult patients with multidrug-resistant tuberculosis at Yangon Regional Tuberculosis Centre, Myanmar: A retrospective study.
    Htun YM; Khaing TMM; Aung NM; Yin Y; Myint Z; Aung ST; Soonthornworasiri N; Silachamroon U; Kasetjaroen Y; Kaewkungwal J
    PLoS One; 2018; 13(12):e0209932. PubMed ID: 30596734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' and health system's delays in the diagnosis and treatment of new pulmonary tuberculosis patients in West Gojjam Zone, Northwest Ethiopia: a cross-sectional study.
    Gebreegziabher SB; Bjune GA; Yimer SA
    BMC Infect Dis; 2016 Nov; 16(1):673. PubMed ID: 27836012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis treatment delays and associated factors within the Zimbabwe national tuberculosis programme.
    Takarinda KC; Harries AD; Nyathi B; Ngwenya M; Mutasa-Apollo T; Sandy C
    BMC Public Health; 2015 Jan; 15():29. PubMed ID: 25631667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential for nosocomial transmission of multidrug-resistant (MDR) tuberculosis in a South African tertiary hospital.
    Bamford CM; Taljaard JJ
    S Afr Med J; 2010 Jul; 100(7):438-41. PubMed ID: 20822590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of GxAlert on the management of rifampicin-resistant tuberculosis patients, Port Moresby, Papua New Guinea.
    Banamu JK; Lavu E; Johnson K; Moke R; Majumdar SS; Takarinda KC; Commons RJ
    Public Health Action; 2019 Sep; 9(Suppl 1):S19-S24. PubMed ID: 31579645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa's Eastern Cape Province.
    Iruedo J; O'Mahony D; Mabunda S; Wright G; Cawe B
    BMC Infect Dis; 2017 Jan; 17(1):91. PubMed ID: 28109255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-clonal evolution of multi-drug-resistant/extensively drug-resistant Mycobacterium tuberculosis in a high-prevalence setting of Papua New Guinea for over three decades.
    Bainomugisa A; Lavu E; Hiashiri S; Majumdar S; Honjepari A; Moke R; Dakulala P; Hill-Cawthorne GA; Pandey S; Marais BJ; Coulter C; Coin L
    Microb Genom; 2018 Feb; 4(2):. PubMed ID: 29310751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.